The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Apr. 26, 2023
Applicant:
Spruce Biosciences, Inc., South San Francisco, CA (US);
Inventors:
Alexis Howerton, South San Francisco, CA (US);
Hal Gerber, South San Francisco, CA (US);
Michael Huang, South San Francisco, CA (US);
Assignee:
SPRUCE BIOSCIENCES, INC., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 9/14 (2006.01); A61K 9/48 (2006.01); A61K 31/573 (2006.01); A61P 5/00 (2006.01); A61P 5/24 (2006.01); A61P 5/38 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/14 (2013.01); A61K 9/48 (2013.01); A61K 9/4825 (2013.01); A61K 31/573 (2013.01); A61P 5/00 (2018.01); A61P 5/24 (2018.01); A61P 5/38 (2018.01); C07D 487/04 (2013.01);
Abstract
The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).